A 24-Month Effects of Methylphenidate Use on Growth in Children and Adolescents With Attention Deficit Hyperactivity Disorder
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective The primary objective of this study was to investigate the effect of methylphenidate (MPH) on height, weight, and body mass index (BMI) in drug-naive children and adolescents with attention deficit hyperactivity disorder (ADHD) over 24 months. The secondary objective was to investigate whether the age of MPH initiation and sex act as risk factors for growth retardation.Methods A total of 82 patients with ADHD were included. Weight, height, and BMI were measured at baseline and every 6 months up to 24 months. Weight, height, and BMI data were converted to z-scores and analyzed using two-way repeated-measures ANOVA and multiple linear regression.Results The z-score of height, weight and BMI decreased from the baseline values. The z-scores of height were at baseline 0.002; 6 months -0.100; 12 months -0.159; 18 months -0.159; 24 months -0.186. The z-scores of weight were at baseline 0.104; 6 months -0.155; 12 months -0.256; 18 months -0.278; 24 months -0.301. Here were no age and sex differences of height, weight, and BMI.Conclusion The use of MPH was associated with attenuation of weight and height gain rates in children and adolescents with ADHD.
Abstract
Objective The primary objective of this study was to investigate the effect of methylphenidate (MPH) on height, weight, and body mass index (BMI) in drug-naive children and adolescents with attention deficit hyperactivity disorder (ADHD) over 24 months. The secondary objective was to investigate whether the age of MPH initiation and sex act as risk factors for growth retardation.Methods A total of 82 patients with ADHD were included. Weight, height, and BMI were measured at baseline and every 6 months up to 24 months. Weight, height, and BMI data were converted to z-scores and analyzed using two-way repeated-measures ANOVA and multiple linear regression.Results The z-score of height, weight and BMI decreased from the baseline values. The z-scores of height were at baseline 0.002; 6 months -0.100; 12 months -0.159; 18 months -0.159; 24 months -0.186. The z-scores of weight were at baseline 0.104; 6 months -0.155; 12 months -0.256; 18 months -0.278; 24 months -0.301. Here were no age and sex differences of height, weight, and BMI.Conclusion The use of MPH was associated with attenuation of weight and height gain rates in children and adolescents with ADHD.
참고문헌 (35)
- Scahill L, "Epidemiology of ADHD in school-age children", Child Adolesc Psychiatr Clin N Am, 9, pp.541~555 (2000)
- Thomas R, "Prevalence of attention-deficit", hyperactivity disorder: a systematic review and meta-analysis, 2015, pp.135, e994~e1001
- Reale L, "Comorbidity prevalence and treatment outcome in children and adolescents with ADHD", Eur Child Adolesc Psychiatry, 26, pp.1443~1457 (2017)
- Lichtenstein P, "Medication for attention deficit-hyperactivity disorder and criminality", N Engl J Med, 367, pp.2006~2014 (2012)
- Renoux C, "Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015", Br J Clin Pharmacol, 82, pp.858~868 (2016)
- Coghill DR, "Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit", hyperactivity disorder: evidence from a systematic review and a meta-analysis, 2014, pp.76, 603~615
- Sang Heon Lee, "Effect of Methylphenidate on Sleep Parameters in Children with ADHD", PSYCHIATRY INVESTIGATION, 9(4), pp.384~390 (2012), 대한신경정신의학회
- Lentferink YE, "Psychostimulants: Influence on body mass index and height in a pediatric population with attention-deficit", hyperactivity disorder?, 2018, pp.28, 530~536
- Harstad EB, "ADHD, stimulant treatment, and growth: a longitudinal study", Pediatrics, 134, pp.e935~e944 (2014)
- Biederman J, "A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects", J Pediatr, 157, pp.635~640.e1 (2010)
- Hart AB, "Genetic factors modulating the response to stimulant drugs in humans", Curr Top Behav Neurosci, 12, pp.537~577 (2012)
- 김영신, "The Reliability and Validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version-Korean Version (K-SADS-PL-K)", Yonsei Medical Journal, 45(1), pp.81~89 (2004), 연세대학교의과대학
- Korea Center for Disease Control and Prevention, "2017 Korean Children and Adolescents Growth Standard", Korea Center for Disease Control and Prevention, Korean Pediatric Society, ~ (2018)
- Cole TJ, "The LMS method for constructing normalized growth stan dards", Eur J Clin Nutr, 44, pp.45~60 (1990)
- Fenton TR, "Using the LMS method to calculate z-scores for the Fenton preterm infant growth chart", Eur J Clin Nutr, 61, pp.1380~1385 (2007)
- Bereket A, "Height, weight, IGF-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment", Horm Res, 63, pp.159~164 (2005)
- Poulton A, "Weight loss on stimulant medication: how does it affect body composition and bone metabolism? - A prospective longitudinal study", Int J Pediatr Endocrinol, 2012, pp.30~ (2012)
- Kilgore BS, "Alterations in cartilage metabolism by neurostimulant drugs", J Pediatr, 94, pp.542~545 (1979)
- Komatsu DE, "Chronic exposure to methylphenidate impairs appendicular bone quality in young rats", Bone, 50, pp.1214~1222 (2012)
- Uddin SMZ, "Methylphenidate regulation of osteoclasts in a dose- and sex-dependent manner adversely affects skeletal mechanical integrity", Sci Rep, 8, pp.1515~ (2018)
- El Halal CDS, "Sleep and weight-height development", J Pediatr (Rio J), 95(Suppl 1), pp.2~9 (2019)
- Jiang YR, "Somatic growth of lean children: the potential role of sleep", World J Pediatr, 10, pp.245~250 (2014)
- Adriani W, "Short-term effects of adolescent methylphenidate exposure on brain striatal gene expression and sexual", endocrine parameters in male rats, 2006, pp.1074, 52~73
- Spencer TJ, "Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD?", J Am Acad Child Adolesc Psychiatry, 45, pp.527~537 (2006)
- Thanos PK, "Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents", Pharmacol Biochem Behav, 87, pp.426~433 (2007)
- Powell SG, "The effects of long-term medication on growth in children and adolescents with ADHD: an observational study of a large cohort of real-life patients", Child Adolesc Psychiatry Ment Health, 9, pp.50~ (2015)
- Zachor DA, "Effects of long-term psychostimulant medication on growth of children with ADHD", Res Dev Disabil, 27, pp.162~174 (2006)
- Schwartz BS, "Attention deficit disorder, stimulant use, and childhood body mass index trajectory", Pediatrics, 133, pp.668~676 (2014)
- Gamo NJ, "Methylphenidate and atomoxetine enhance prefrontal function through alpha2-adrenergic and dopamine D1 receptors", J Am Acad Child Adolesc Psychiatry, 49, pp.1011~1023 (2010)
- Sahin S, "Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder", Int J Psychiatry Clin Pract, 18, pp.280~287 (2014)
- Pliszka SR, "Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit", hyperactivity disorder, 2006, pp.45, 520~526
- Zhang H, "Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD", Neuropediatrics, 41, pp.55~59 (2010)
- Kim HW, "Effect of methylphenidate on height and weight in Korean children and adolescents with attention-deficit", hyperactivity disorder: a retrospective chart review, 2014, pp.24, 448~453
- Diez-Suarez A, "Weight, height, and body mass index in patients with attention-deficit", hyperactivity disorder treated with methylphenidate, 2017, pp.27, 723~730
- Swanson JM, "Effects of stimulant medication on growth rates across 3 years in the MTA follow-up", J Am Acad Child Adolesc Psychiatry, 46, pp.1015~1027 (2007)